Introduction: Coronavirus is a global pandemic that has had a devastating impact on healthcare systems and put them through their paces. Individuals in the Covid-19 study have not had their hospitalized length of stay (LOS) or its determinants evaluated; thus, identifying the characteristics of those patients is critical to understanding their outcomes.

Objective: To study hospitalization (LOS) for coronavirus patients from a single center in KSA and to determine the predictors for longer LOS.

Methods: A retrospective cohort study using electronic medical records (EMR) of hospitalized coronavirus patients from a single hospital in Saudi Arabia between May 1, 2020 - July 30, 2020, was conducted. Only adults with complete EMR and >1 day LOS were included. Descriptive statistics, mean and mean differences, and Multiple linear regression was performed using Excel, and SAS software.

Results: A total of 977 adults were included. nearly 34% of them were ≥ 50 years old and >80% were females. More than 70 % had mild to moderate symptoms and 45% had either diabetes or hypertension. The average LOS was 8.78 (SD 9.28). Patients who were females, had either critical or severe symptoms, on mechanical ventilation, diabetics, and those who used Ceftriaxone had significant (p-value <.05) longer LOS. Interestingly, patients who administered Zinc Sulfate showed shorter LOS (mean diff.= -2.76, p-value 0.0008).

Conclusion: Patients in our study stay in the hospital for Covid-19 is around 9 days in the usual case. Women, diabetics, and patients experiencing severe or critical symptoms should all get special attention from healthcare experts. Additionally, they must reduce the usage of Ceftriaxone in patients who do not need it and deliver Zinc Sulfate to those who do require it.